University Cancer Specialists
Hematology
Dr. Timothy J. Panella, MD
|
|
Give Review
Timothy Panella is an expert in the field of Hematology. He attended University of Tennessee College of Medicine. He received 1 awards: "Regional Top Doctor". Timothy Panella has written publications. He has 23 publications published with PubMed. The lastest paper is: 'Relative sedimentation of hematopoietic progenitors in human cord blood, peripheral blood, and bone marrow as determined by counterflow centrifugal elutriation.' Timothy J. Panella accepts all Medicare patients.
Publications
- Is the TNM Staging System for Breast Cancer Still Relevant in the Era of Biomarkers and Emerging Personalized Medicine for Breast Cancer - An Institution's 10-year Exp...
- Prognostic Value of Breast Cancer Subtypes, Ki-67 Proliferation Index, Age, and Pathologic Tumor Characteristics on Breast Cancer Survival in Caucasian Women.
- Metastasis of squamous cell carcinoma of the Bladder to the heart: case report and review of the literature.
- Phase II trial of pyrazoloacridine in advanced non-small cell carcinoma of the lung--a Kansas Cancer Institute and Thompson Cancer Survival Center Study.
- Sarcoma of mandible.
- A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast Cancer.
- Relationship between response rate and median survival in patients with advanced nonsmall cell lung-Cancer - comparison of onconase(r) with other antiCancer agents.
- Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma.
- Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse.
- Phase II study of Didemnin B in central Nervous system tumors: a Southwest Oncology Group study.
- Relative sedimentation of hematopoietic progenitors in human cord blood, peripheral blood, and bone marrow as determined by counterflow centrifugal elutriation.
- Evaluation of multimodality treatment of locoregional esophageal Carcinoma by Southwest Oncology Group 9060.
- A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell Carcinoma of the head and neck.
- Phase II trial and cost Analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study.
- Effect of thimerosal in Leukemia, in leukemic cell lines, and on normal hematopoiesis.
- Platelets acquire a secretion defect after high-dose chemotherapy.
- Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human ...
- Absence of phosphatidylinositol (PI)-linked proteins in a very early human multipotential haematopoietic marrow cell.
- Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast Cancer.
- Paraneoplastic hepatopathy associated with soft tissue sarcoma.
- Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
- High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine.
Schools
University Of Tennessee Health Science Center College Of Medicine
Worcester Meml Hospital
Duke University
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Network E
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- GEHA
- HealthSmart
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- POMCO Group
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Awards
- Regional Top Doctor
Education
-
Duke University Hospital -
University of Tennessee College of Medicine
Hospital
-
University of Tennessee Medical Center
Drug Facts
| NPI NUMBER | 1801908223 | |
| NPPES Provider LastName | PANELLA | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 379201524 | |
| NPPES Provider State | TN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 977.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 108.0 | |
| Percent Opioid Claims | 11.05 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801908223 |
| Last Name Of The Provider | PANELLA |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Ronald H. Lands, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard T. Lee, MD |
|
Dr. Robert D. Schumaker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan M. Grossman, MD |
|
|
Dr. Stephanie B. Cross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David N. Aljadir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brenda P. Nicholson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. S S. McCachren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy W. Dobbs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Takuo Sonoda, MD |
|
|
Dr. Raymond Brig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wahid T. Hanna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert C. Ebenezer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan E. Schrock, MD
This Doctor is OpenDoctor Recommended.
|